SANOFI (SNW.DE) Stock Price & Overview
FRA:SNW • FR0000120578
The current stock price of SNW.DE is 77.71 EUR. Today SNW.DE is down by -2.02%. In the past month the price decreased by -4.06%. In the past year, price decreased by -29.32%.
SNW.DE Key Statistics
- Market Cap
- 187.692B
- P/E
- 9.94
- Fwd P/E
- 9.19
- EPS (TTM)
- 7.82
- Dividend Yield
- 3.80%
SNW.DE Stock Performance
SNW.DE Stock Chart
SNW.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SNW.DE. When comparing the yearly performance of all stocks, SNW.DE is a bad performer in the overall market: 89.34% of all stocks are doing better.
SNW.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SNW.DE. SNW.DE has an average financial health and profitability rating.
SNW.DE Earnings
On January 29, 2026 SNW.DE reported an EPS of 1.53 and a revenue of 11.30B. The company beat EPS expectations (4.58% surprise) and missed revenue expectations (-2.08% surprise).
SNW.DE Forecast & Estimates
30 analysts have analysed SNW.DE and the average price target is 98.4 EUR. This implies a price increase of 26.62% is expected in the next year compared to the current price of 77.71.
For the next year, analysts expect an EPS growth of 8.1% and a revenue growth 6.17% for SNW.DE
SNW.DE Groups
Sector & Classification
SNW.DE Financial Highlights
Over the last trailing twelve months SNW.DE reported a non-GAAP Earnings per Share(EPS) of 7.82. The EPS increased by 1.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.71% | ||
| ROA | 9.85% | ||
| ROE | 17.49% | ||
| Debt/Equity | 0.22 |
SNW.DE Ownership
SNW.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SAN | SANOFI | 9.01 | 187.74B | ||
| 1SAN | SANOFI | 9.18 | 187.378B | ||
| UNC | UCB SA | 25.58 | 51.176B | ||
| UCB | UCB SA | 24.48 | 50.164B | ||
| MRK | MERCK KGAA | 12.82 | 49.217B | ||
| BAYN | BAYER AG-REG | 7.44 | 37.111B | ||
| 1BAYN | BAYER AG-REG | 7.7 | 36.973B | ||
| IPN | IPSEN | 14.24 | 13.795B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 10.059B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.19 | 9.95B | ||
| VIRP | VIRBAC SA | 16.34 | 2.907B | ||
| DMP | DERMAPHARM HOLDING SE | 15.21 | 2.062B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About SNW.DE
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Company Info
SANOFI
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE FR
Employees: 84587
Phone: 33153774000
SANOFI / SNW.DE FAQ
Can you describe the business of SANOFI?
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
What is the stock price of SANOFI today?
The current stock price of SNW.DE is 77.71 EUR. The price decreased by -2.02% in the last trading session.
Does SANOFI pay dividends?
SANOFI (SNW.DE) has a dividend yield of 3.8%. The yearly dividend amount is currently 3.79.
What is the ChartMill technical and fundamental rating of SNW stock?
SNW.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Would investing in SANOFI be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SNW.DE.
What is the expected growth for SNW stock?
The Revenue of SANOFI (SNW.DE) is expected to grow by 6.17% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is SANOFI worth?
SANOFI (SNW.DE) has a market capitalization of 187.69B EUR. This makes SNW.DE a Large Cap stock.